News Image

Tuesday's pre-market session: top gainers and losers

By Mill Chart

Last update: Apr 23, 2024

As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Pre-market gainers

TickerChangeComment
CYN95.95%CYNGN INC (NASDAQ:CYN) recorded a 95.95% increase in share price during the pre-market session, reaching $0.24 on Tuesday. Also in the previous session NASDAQ:CYN had a very good day: shares closed with a 11.93% gain.
PEGY43.67%During Tuesday's pre-market session, PINEAPPLE ENERGY INC (NASDAQ:PEGY) exhibited strong growth, with the stock price climbing 43.67% to $0.07. NASDAQ:PEGY seems to be recovering from a -10.2% loss in the previous session.
SMFL42.99%SMART FOR LIFE INC's (NASDAQ:SMFL) shares surged 42.99% to reach $6.22 during the pre-market session on Tuesday. Yesterday's gain of 804.0% continues in today's pre-market with 42.99%.
HWH38.28%HWH INTERNATIONAL INC's (NASDAQ:HWH) shares surged 38.28% to reach $1.77 during the pre-market session on Tuesday. The stock is trading 20.75% higher than a month ago.
NKGN24.49%NKGEN BIOTECH INC (NASDAQ:NKGN) rose 24.49% to $1.83 during Tuesday's pre-market session. Today's pre-market session builds upon the previous day's success, as NASDAQ:NKGN continues its upward trajectory following a 32.91% gain.
ICUCW23.76%LMF ACQUISITION OPP -A -CW26's (NASDAQ:ICUCW) stock price is advancing with 23.76% to a price of $0.1. After yesterday's drop of -10.22%, it looks like it is bouncing back in today's pre-market session.
TLSA21.99%Pre-market trading on Tuesday showed positive momentum for TIZIANA LIFE SCIENCES LTD (NASDAQ:TLSA), as the stock price advanced 21.99% to reach $0.92. The positive momentum from yesterday's 13.15% gain carries forward into today's pre-market session, with an additional 21.99% increase. yesterday the company released their earnings. Earlier today the company had a press release: Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program.
CXAIW21.18%During Tuesday's pre-market session, KINS TECH GROUP CL A -CW25 (NASDAQ:CXAIW) experienced a 21.18% increase, with the stock price reaching $0.36. The stock is trading 48.5% higher than a month ago.
SAVAW20.93%CASSAVA SCIENCES INC-28's (NASDAQ:SAVAW) stock price increased by 20.93% to $0.52. Shareholders saw the stock price going 89.81% lower in the past month.
HIBB18.84%HIBBETT INC's (NASDAQ:HIBB) stock price increased by 18.84% to $86.15. A press release (Hibbett, Inc. Announces Definitive Agreement to be Acquired by JD Sports Fashion plc) was released earlier today.

For the full premarket gainers list go to our premarket gainers page.

Today's pre-market losers

TickerChangeComment
DCFC-62.91%TRITIUM DCFC LTD's (NASDAQ:DCFC) stock price decreased by 62.91% to $1.35. Shareholders saw the stock price going 73.62% lower in the past month.
ABEO-46.74%ABEONA THERAPEUTICS INC's (NASDAQ:ABEO) stock price recorded a 46.74% decrease, falling to $3.92. A press release (Abeona Therapeutics Provides Regulatory Update on Pz-cel) was released yesterday.
GWAV-44.42%Investors observed a 44.42% decline in GREENWAVE TECHNOLOGY SOLUTIO's (NASDAQ:GWAV) stock price, which now stands at $0.07 during Tuesday's pre-market session. Shareholders saw the stock price going 85.36% lower in the past 3 months.
CALX-15.76%The stock price of CALIX INC (NYSE:CALX) is experiencing a decline of 15.76%, reaching $24.9 in today's pre-market session on Tuesday. A press release (Calix Releases First Quarter 2024 Financial Results) was released yesterday.
PHIO-15.51%PHIO PHARMACEUTICALS CORP's (NASDAQ:PHIO) shares fell 15.51% to $0.7. After running up 29.69% in yesterday's session, NASDAQ:PHIO is pulling back pre-market.
TTOO-12.97%T2 BIOSYSTEMS INC's (NASDAQ:TTOO) shares fell 12.97% to $2.75 during Tuesday's pre-market session. In the last 3 months the share price dropped with 25.12%.
CSLR-12.62%COMPLETE SOLARIA INC's (NASDAQ:CSLR) stock price decreased by 12.62% to $0.34. Yesterday's drop of -13.53% continued in today's pre-market session with another decline of 12.62% A press release (Retail Stock Sector and Chairman T.J. Rodgers Invest in Complete Solaria) was released two days ago.
SSL-11.85%The stock price of SASOL LTD-SPONSORED ADR (NYSE:SSL) is experiencing a decline of 11.85%, reaching $6.99 in today's pre-market session on Tuesday. Shareholders saw the stock price going 39.51% lower is the past 6 months.
JAGX-11.4%Tuesday's pre-market session showed a 11.4% decrease in the stock price of JAGUAR HEALTH INC (NASDAQ:JAGX), reaching $0.16. After a strong performance yesterday with a 14.66% gain, NASDAQ:JAGX shows signs of retracement with a 11.4% decline in today's pre-market session.
SPCB-10.98%Investors observed a 10.98% decline in SUPERCOM LTD's (NASDAQ:SPCB) stock price, which now stands at $0.26 during Tuesday's pre-market session. Prices are quite volatile now: this is a reversal from yesterday's 31.68% gain.

For the full premarket loser list go to our premarket losers page.

Back

TIZIANA LIFE SCIENCES LTD

NASDAQ:TLSA (5/17/2024, 7:00:01 PM)

After market: 0.736 -0.01 (-1.08%)

0.744

+0.06 (+9.25%)

TLSA News

News Image6 days ago - Tiziana Life Sciences Ltd.Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab
News Image24 days ago - Tiziana Life Sciences Ltd.Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab
News Image24 days ago - Tiziana Life Sciences Ltd.Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing...

News Image26 days ago - Market News VideoTuesday Sector Leaders: Diagnostics, Biotechnology Stocks
News Image26 days ago - Tiziana Life Sciences Ltd.Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program
News Image26 days ago - Tiziana Life Sciences Ltd.Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program

NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing...

News Imagea month ago - Tiziana Life Sciences Ltd.Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded Access Program
News Imagea month ago - Tiziana Life Sciences Ltd.Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®
News Imagea month ago - Tiziana Life Sciences Ltd.Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®

- Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of...

News Imagea month ago - InvestorPlace7 Battered Blue-Chip Stocks to Bounce From Your Portfolio This Spring

Not all big companies are doing well in the stock market. For various reasons, these battered blue-chip stocks are struggling mightily.

News Imagea month ago - Tiziana Life Sciences Ltd.Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology

Oral presentation of study shows intranasal foralumab attenuates microglial activation and disease progression in multiple sclerosis (MS) patients with PIRA as measured by changes in PET scans

News Imagea month ago - Tiziana Life Sciences Ltd.Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology

Oral presentation of study shows intranasal foralumab attenuates microglial activation and disease progression in multiple sclerosis (MS) patients with...

TLSA Links
Follow us for more